Today: 10 June 2026

Michał Rogucki

Zscaler stock slides 9% premarket after results; higher spend spooks traders

Zscaler stock slides 9% premarket after results; higher spend spooks traders

Zscaler shares dropped 8.6% to $152.99 in premarket trading after reporting a wider quarterly GAAP loss despite a 26% revenue increase and raised guidance. The company cited higher sales and R&D costs and flagged cautious IT spending on large deals. Annual recurring revenue rose 25% to $3.36 billion. Zscaler forecast April-quarter revenue of $834 million to $836 million.
Paramount Skydance (PSKY) stock price pops in premarket as Netflix steps aside on Warner Bros deal

Paramount Skydance (PSKY) stock price pops in premarket as Netflix steps aside on Warner Bros deal

Paramount Skydance shares jumped 9.5% to $12.24 in premarket trading Friday after Netflix declined to match its $31-per-share bid for Warner Bros Discovery. California’s attorney general said the deal faces an open investigation, and analysts warned of possible regulatory challenges. Paramount’s offer includes a $7 billion termination fee and a ticking fee if closing is delayed past September 2026.
Haleon PLC stock ticks up after earnings whiplash; here’s what matters for HLN shares

Haleon PLC stock ticks up after earnings whiplash; here’s what matters for HLN shares

Haleon shares rose 1% to 398.2 pence in early London trading Friday after sharp swings earlier in the week. The company reported 2025 revenue of £11.03 billion and forecast 3%-5% organic revenue growth for 2026, with a £500 million buyback planned. CEO Brian McNamara said U.S. growth is expected to return this year. Haleon’s next trading update is due April 29.
GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

GSK share price today: stock edges up after Japan and China reviews, plus $950 million 35Pharma deal

GSK shares rose 0.74% to 2,183 pence by 0855 GMT after Japan and China accepted regulatory filings for two experimental liver-disease drugs. The company also agreed to buy Canada’s 35Pharma for $950 million, adding a pulmonary hypertension asset. GSK closed down 2.12% the previous session. Investors await first-quarter results on April 29.
27 February 2026
HSBC share price steadies near highs as investors weigh new targets and Singapore sale talk

HSBC share price steadies near highs as investors weigh new targets and Singapore sale talk

HSBC shares rose 0.4% to 1,404 pence in early London trade Friday, staying near recent highs after annual results. The bank reported 2025 pretax profit of $29.9 billion, down 7% after one-off charges, and approved a fourth interim dividend of $0.45 per share. HSBC has started a sale process for its Singapore life insurance manufacturing unit, seeking a valuation above $1 billion.
27 February 2026
RELX share price today: stock edges up as buybacks keep traders watching

RELX share price today: stock edges up as buybacks keep traders watching

RELX shares rose 0.5% to 2,537.78 pence in early London trading Friday, following gains of 6.25% and 4.55% earlier in the week. The company repurchased 500,000 shares Thursday and is running a £450 million buyback through March 20. RELX also applied for a block listing of 80,000 shares for an employee plan, with admission expected March 2. The next trading update is set for April 23.
27 February 2026
Rolls-Royce share price ticks up as RR.L steadies after big buyback, outlook lift

Rolls-Royce share price ticks up as RR.L steadies after big buyback, outlook lift

Rolls-Royce shares rose 0.5% to 1,359 pence in early London trading Friday, after a 9.1% surge Thursday that helped lift the FTSE 100 to a record close. The company reported £3.46 billion in 2025 operating profit and launched a share buyback of up to £2.3 billion, set to run through December 23. Rolls-Royce forecasts £4.0–£4.2 billion profit and £3.6–£3.8 billion free cash flow in 2026.
27 February 2026
Brambles share price rises as buy-back filing shows steady pace — what to watch next for ASX:BXB

Brambles share price rises as buy-back filing shows steady pace — what to watch next for ASX:BXB

Brambles Ltd closed up 0.6% at A$25.08 after disclosing it bought back 101,855 shares for A$2.55 million on Feb. 25, with total repurchases reaching 12.56 million shares. The company cancelled the latest shares, leaving 1,357,878,736 on issue. Brambles has flagged it may pause buy-backs if conditions change. The interim dividend goes ex-dividend March 11, with payment due April 9.
Telstra share price ends higher on buyback filing as dividend timeline sharpens focus

Telstra share price ends higher on buyback filing as dividend timeline sharpens focus

Telstra shares closed up 0.8% at A$5.18 Friday after the company bought back nearly 1.9 million shares for A$9.9 million, part of a buyback now totaling A$671 million. The stock traded ex-dividend this week, with a 10.5 cent interim payout due March 27. The S&P/ASX 200 rose 0.25%. Telstra recently raised its buyback cap to A$1.25 billion following a strong earnings report.
1 24 25 26 27 28 33

Stock Market Today

  • Northamber PLC Buys Back 200,000 Shares at 25p Each
    June 10, 2026, 9:06 AM EDT. Northamber PLC (AIM: NAR), a value-add Audio Visual and IT distributor, announced the purchase of 200,000 ordinary shares at 25 pence per share. These shares are to be issued to a consultant in exchange for services provided. Post-transaction, Northamber's total issued share capital will be 27,413,404 shares, with 27,113,404 carrying voting rights after accounting for 300,000 shares held in treasury. This transaction is disclosed under the UK's Market Abuse Regulation and relevant transparency rules. The shares were bought on the AIM market at 16:21:24. Investors can use the updated total share count to assess their shareholdings for regulatory notification requirements.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Go toTop